Want to see JP:9341 full AI Analyst Report?
9341 Stock Chart & Stats
¥582.00
-¥9.00(-0.65%)
At close: 4:00 PM EST
¥582.00
-¥9.00(-0.65%)
Day’s Range― - ―
52-Week Range¥541.00 - ¥748.00
Previous CloseN/A
Volume164.20K
Average Volume (3M)127.01K
Market Cap
¥11.18B
Enterprise Value¥6.87K
Total Cash (Recent Filing)¥5.32B
Total Debt (Recent Filing)¥735.71M
Price to Earnings (P/E)40.3
Beta0.88
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)15.88
Shares Outstanding17,838,100
10 Day Avg. Volume126,090
30 Day Avg. Volume127,006
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)1.38
Price to Sales (P/S)0.82
P/FCF Ratio-202.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)157.5
Revenue Forecast (FY)¥15.40B
Bulls Say, Bears Say
Bulls Say
Revenue Growth MomentumSustained ~24% revenue growth and a multi-year expansion trend provide durable demand validation and scale. Steady top-line expansion supports reinvestment in product development, sales coverage and fixed-cost absorption, giving time and resources to restore margins over the medium term.
Conservative LeverageA low debt-to-equity profile and conservative leverage preserve financial flexibility through cash-flow volatility. This reduces refinancing risk, supports the ability to fund strategic initiatives or weather temporary cash shortfalls, and limits downside from interest-rate or funding shocks.
Healthy Asset Growth Supporting ScaleConsistent asset growth indicates investment in capacity and capabilities that support scaling the business. Scale can deepen customer relationships, spread fixed costs, and enable incremental margin recovery if management improves operational efficiency and monetization of existing assets.
Bears Say
Cash-generation ReversalA sharp drop to very low operating cash flow and negative free cash flow is a durable concern: it impairs the firm's ability to self-fund capex, R&D, dividends or M&A. Persistent weak cash conversion raises financing needs and limits strategic optionality over months to years.
Margin And ROE CompressionMaterial gross- and operating-margin erosion and falling ROE signal weakening competitive economics. If sustained, lower margins reduce free cash generation and returns on invested capital, forcing either structural cost cuts, price increases that risk demand, or lower reinvestment capacity.
Earnings-quality DeteriorationAn ~80% drop in EPS alongside negative FCF points to a meaningful erosion in earnings quality and predictability. Such a sharp decline reduces management credibility, increases volatility in shareholder returns, and may force defensive capital-allocation choices that hamper long-term growth.
GENOVA Inc. News
9341 FAQ
What was GENOVA Inc.’s price range in the past 12 months?
GENOVA Inc. lowest stock price was ¥541.00 and its highest was ¥748.00 in the past 12 months.
What is GENOVA Inc.’s market cap?
GENOVA Inc.’s market cap is ¥11.18B.
When is GENOVA Inc.’s upcoming earnings report date?
GENOVA Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 92 days.
How were GENOVA Inc.’s earnings last quarter?
GENOVA Inc. released its earnings results on Aug 10, 2026. The company reported ¥14.409 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is GENOVA Inc. overvalued?
According to Wall Street analysts GENOVA Inc.’s price is currently Overvalued.
Does GENOVA Inc. pay dividends?
GENOVA Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 4.69%. See more information on GENOVA Inc. dividends here
What is GENOVA Inc.’s EPS estimate?
GENOVA Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GENOVA Inc. have?
GENOVA Inc. has 17,838,100 shares outstanding.
What happened to GENOVA Inc.’s price movement after its last earnings report?
GENOVA Inc. reported an EPS of ¥14.409 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.073%.
Which hedge fund is a major shareholder of GENOVA Inc.?
Currently, no hedge funds are holding shares in JP:9341
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GENOVA Inc.
Operating within Japan, GENOVA, Inc. focuses on the digital healthcare market, providing both medical platform services and smart clinic solutions. Its offerings include Medical Doc, a comprehensive online platform that distributes diverse content, such as articles for healthcare institutions, patient experience narratives, treatment demonstrations, and general medical information. The company also developed Smart Clinic, an innovative telemedicine and consultation service that enables users to receive medical care from their homes or workplaces, bypassing the need for in-person hospital visits. Additionally, GENOVA offers a suite of clinic automation tools, including NOMOCa-Stand, a user-friendly automatic machine for reception and payments; NOMOCa-Regi, a dedicated self-pay terminal for clinic environments; and CLINIC BOT, an AI-driven chatbot system. GENOVA, Inc. was established in 2005 and is based in Tokyo, Japan.
Technical Analysis
Medley
―
―
Welby Inc.
―
Mental Health Technologies Co. Ltd.
―
Wellness Communications Corporation
―